These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension. Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502 [TBL] [Abstract][Full Text] [Related]
23. Clinical diagnostic value of circulating serum miR-509-3p in pulmonary arterial hypertension with congenital heart disease. Tang P Hellenic J Cardiol; 2020; 61(1):26-30. PubMed ID: 29890280 [TBL] [Abstract][Full Text] [Related]
24. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension. Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969 [TBL] [Abstract][Full Text] [Related]
25. Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension. Di Benedetto P; Guggino G; Manzi G; Ruscitti P; Berardicurti O; Panzera N; Grazia N; Badagliacca R; Riccieri V; Vizza CD; Radchenko G; Liakouli V; Ciccia F; Cipriani P; Giacomelli R Arthritis Res Ther; 2020 Jun; 22(1):127. PubMed ID: 32487240 [TBL] [Abstract][Full Text] [Related]
26. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291 [TBL] [Abstract][Full Text] [Related]
27. Serum High-Density Lipoprotein Cholesterol is Significantly Associated with the Presence and Severity of Pulmonary Arterial Hypertension: A Retrospective Cross-Sectional Study. Wang GF; Guan LH; Zhou DX; Chen DD; Zhang XC; Ge JB Adv Ther; 2020 May; 37(5):2199-2209. PubMed ID: 32239458 [TBL] [Abstract][Full Text] [Related]
28. Galectin-3 Binding Protein and Galectin-1 Interaction in Breast Cancer Cell Aggregation and Metastasis. Lin TW; Chang HT; Chen CH; Chen CH; Lin SW; Hsu TL; Wong CH J Am Chem Soc; 2015 Aug; 137(30):9685-93. PubMed ID: 26168351 [TBL] [Abstract][Full Text] [Related]
29. Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension. Simpson CE; Damico RL; Hummers L; Khair RM; Kolb TM; Hassoun PM; Mathai SC Pulm Circ; 2019; 9(3):2045894019859477. PubMed ID: 31384431 [TBL] [Abstract][Full Text] [Related]
30. Mortality and prognostic factors in connective tissue disease-associated pulmonary arterial hypertension patients complicated with right heart failure. Deng X; Jiang N; Huang C; Zhou S; Peng L; Zhang L; Liu J; Wang L; Zhou J; Wang Q; Weng L; Peng J; Zhao J; Li M; Zeng X Int J Rheum Dis; 2023 May; 26(5):862-869. PubMed ID: 36892249 [TBL] [Abstract][Full Text] [Related]
31. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4. He J; Li X; Luo H; Li T; Zhao L; Qi Q; Liu Y; Yu Z J Am Soc Hypertens; 2017 May; 11(5):275-289.e2. PubMed ID: 28431936 [TBL] [Abstract][Full Text] [Related]
33. Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2. Gallo V; Arienzo A; Iacobelli S; Iacobelli V; Antonini G Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806317 [TBL] [Abstract][Full Text] [Related]
34. Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension. Mazurek JA; Horne BD; Saeed W; Sardar MR; Zolty R Heart Lung Circ; 2017 Nov; 26(11):1208-1215. PubMed ID: 28242288 [TBL] [Abstract][Full Text] [Related]
35. Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension. Chang WT; Shih JY; Hong CS; Lin YW; Chen YC; Ho CH; Chen ZC; Roan JN; Hsu CH ESC Heart Fail; 2021 Aug; 8(4):3082-3092. PubMed ID: 33955184 [TBL] [Abstract][Full Text] [Related]
36. Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension. Fulton DJR; Li X; Bordan Z; Wang Y; Mahboubi K; Rudic RD; Haigh S; Chen F; Barman SA Antioxid Redox Signal; 2019 Nov; 31(14):1053-1069. PubMed ID: 30767565 [No Abstract] [Full Text] [Related]
37. Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: a single-center retrospective study. Wang J; Wang Y; Li X; Huang Y; Sun X; Wang Q; Zhang M BMC Pulm Med; 2020 Oct; 20(1):272. PubMed ID: 33076877 [TBL] [Abstract][Full Text] [Related]
38. Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients. Wojciechowska C; Romuk E; Nowalany-Kozielska E; Jacheć W Hellenic J Cardiol; 2017; 58(5):350-359. PubMed ID: 28363768 [TBL] [Abstract][Full Text] [Related]
39. Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension. Fenster BE; Lasalvia L; Schroeder JD; Smyser J; Silveira LJ; Buckner JK; Brown KK Heart Vessels; 2016 Jun; 31(6):939-46. PubMed ID: 25976729 [TBL] [Abstract][Full Text] [Related]
40. Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients. Lan WF; Deng Y; Dai P; Wu DD; Hu J; Liao J; Meng H Lupus; 2024 Feb; 33(2):155-165. PubMed ID: 38182135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]